# Valo Therapeutics Ltd: Research, Helsinki, Finland

> Valo Therapeutics Ltd: Valo Therapeutics Ltd, also known as ValoTx, is a clinical-stage biotechnology company based in Helsinki, Finland.

Source: https://millionrounds.com/startup/valo-therapeutics-ltd (Millionrounds; every figure on the page links to its filing or article)

Finland · [Research startup](https://millionrounds.com/companies)

# Valo Therapeutics Ltd

Valo Therapeutics Ltd, also known as ValoTx, is a clinical-stage biotechnology company based in Helsinki, Finland.

Email

Funding reported Last round: Grant

Research Helsinki, Finland

Follow Valo Therapeutics Ltd and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fvalo-therapeutics-ltd)

Company summary

- **Founded:** 2016 10 years old
- **Team:** 11 11 to 50 people
- **Funding reported:** 20.6M as listed, currency not stated
- **Last round:** Grant Feb 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Valo Therapeutics Ltd has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Valo Therapeutics Ltd

Valo Therapeutics Ltd, also known as ValoTx, is a clinical-stage biotechnology company based in Helsinki, Finland.

Founded in 2016 as a spin-out from the University of Helsinki, ValoTx focuses on developing innovative immunotherapies aimed at treating cancer and infectious diseases. The company is recognized for its expertise in oncolytic virotherapy, utilizing a unique platform that combines oncolytic viruses with disease-specific peptide vaccination. Valo's proprietary technology, PeptiCRAd, is central to its approach. This platform merges oncolytic virotherapy with peptide vaccination, allowing for targeted immune responses against cancerous cells. The company's lead product, PeptiCRAd-1, is currently in a Phase 1 clinical trial, designed to treat cancers expressing specific tumor antigens. Additionally, Valo is developing PeptiCHIP, a diagnostic tool for rapid identification of tumor neoantigens, and is exploring strategies to enhance immune responses against viral infections, including Covid-19. Valo Therapeutics aims to provide personalized therapeutic options for patients and support healthcare providers and pharmaceutical partners in advancing immunotherapy solutions.

## What company datasets say Valo Therapeutics Ltd raised

Funding, as reported

Reported in all **20.6M** in the source's currency

Rounds **4**

Last round **Grant**

Last round size **20.9M**

Last round date **Feb 2023**

Investors listed **5**

## Founders and team

From Valo Therapeutics Ltd's own website: 4 on the team.

- **Dr Austin Smith** Medical Director
- **Dr. Andrew Dean** Member of the Board
- **Dr. Carlos de Sousa** Member of the Board
- **Dr. Paul Porter** Member of the Board

Advisers *Prof. Vincenzo Cerullo*

## The company, in detail

What they build

Known for

biotechnology research immunology hospital & health care immunotherapy oncolytic viruses oncology b2b

Built with from their website

Google Tag Manager PWA YouTube Google Workspace Viewport Meta Google Meet Microsoft Exchange Microsoft 365 Apps & Services Mobile Friendly Drupal

+8 more

jQuery Apple iOS HTTP/3 Microsoft Exchange Online HSTS Nginx Microsoft 365 Outlook

- **Sector:** Research
- **Industry code:** NAICS 541714, 325412
- **Region:** Uusimaa
- **Revenue:** 10.5M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/valo-therapeutics)

## Research in Finland

Startups like it

- [**TILT Biotherapeutics Ltd** Helsinki · founded 2013](https://millionrounds.com/startup/tilt-biotherapeutics-ltd)
- [**Enifer** Espoo · founded 2020](https://millionrounds.com/startup/enifer-2)
- [**Volare Solutions** Helsinki · founded 2021](https://millionrounds.com/startup/volare-solutions)
- [**Linio Biotech** Helsinki · founded 2017](https://millionrounds.com/startup/linio-biotech)
- [**Boreal Bioproducts** Espoo · founded 2018](https://millionrounds.com/startup/boreal-bioproducts)
- [**KÄÄPÄ Biotech** Lohja · founded 2018](https://millionrounds.com/startup/k-p-biotech-2)
- [**Aurealis Therapeutics** Kuopio · founded 2015](https://millionrounds.com/startup/aurealis-therapeutics)
- [**Rappta Therapeutics** Helsingfors · founded 2019](https://millionrounds.com/startup/rappta-therapeutics)

## Is this your company?

Add your raise, your deck and your story, and put Valo Therapeutics Ltd in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)